Episode notes
This week, we have conversations on data integration with Lithuanian company Vugene, and we talk protein degradation with Amphista Therapeutics.
Multi-omics
Vugene is a Lithuanian bioinformatics company focused on multi-omics data integration. Founded in 2021 by CTO Juozas Gordevičius, the company is headquartered in Kaunas.
Its core offering is a software platform designed to help researchers make sense of complex biological datasets — including transcriptomics, proteomics, metabolomics, and epigenomics — without requiring deep coding expertise.
The platform is a flexible, modular tool for academic and commercial labs that need to process high-thro ...
Keywords
biotechbiotechnologyLithuaniaproteinVugeneprotein degradationAmphista Therapeuticsmulti-omics